Italy Fines Apple €98.6 Million Over App Store Dominance 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Online Availability of Sanofi Group's Half-Year Financial Report for 2017
Paris, France - July 31, 2017 - Sanofi announces that its half-year financial report for the period ending June 30, 2017 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.
This document may be found on the company's corporate website: www.sanofi.com and down loaded from the "Investors" page under the heading "Regulated Information in France."
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Contacts:
| Media Relations | Investor Relations |
| Laurence Bollack | George Grofik |
| Tel.:+ 33 (0) 1 53 77 46 46 | Tel.: + 33 (0) 1 53 77 45 45 |
| [email protected] | [email protected] |
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/2d7a97ed-e9fe-4573-8b48-e69b423af88a
